Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability

Arthritis Care and Research

Volumn 63, Issue 11, 2011, Pages 1605-1612

  Dalbeth, Nicola ^a   Petrie, Keith J ^a   House, Meaghan ^a   Chong, Jimmy ^a   Leung, Wingchi ^a   Chegudi, Rini ^a   Horne, Anne ^a   Gamble, Greg ^a   McQueen, Fiona M ^a   Taylor, William J ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

URATE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COMPREHENSION; DIET; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PERCEPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GOUT; GOUT SUPPRESSANTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEGATIVISM; NEW ZEALAND; PERCEPTION; PROGNOSIS; QUESTIONNAIRES; REGRESSION ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 80055101035     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20570     Document Type: Article

References (31)

1. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24. (Pubitemid 44620440)
2. Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, et al. Treatment of chronic gout: can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001; 28: 577-80. (Pubitemid 32202663)
3. Shoji A, Yamanaka H, Kamatani N,. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51: 321-5. (Pubitemid 38725128)
4. Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A,. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47: 356-60. (Pubitemid 34856121)
5. Roddy E, Zhang W, Doherty M,. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007; 66: 1311-5. (Pubitemid 47492473)
6. Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, et al. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 2009; 11: R46.
7. Solomon DH, Avorn J, Levin R, Brookhart MA,. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 2008; 67: 609-13. (Pubitemid 351571922)
8. Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW,. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 2006; 12: 61-5. (Pubitemid 44309598)
9. Mikuls TR, Curtis JR, Allison JJ, Hicks RW, Saag KG,. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system. J Rheumatol 2006; 33: 562-6. (Pubitemid 43334581)
10. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG,. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 2005; 44: 1038-42. (Pubitemid 41487179)
11. Petrie KJ, Weinman J,. Why illness perceptions matter. Clin Med 2006; 6: 536-9. (Pubitemid 46052003)
12. Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal EA, Patrick-Miller L, et al. Illness representations: theoretical foundations. In:, Petrie KJ, Weinman J, editors. Perceptions of health and illness: current research and applications. London: Hanwood Academic; 1997. p. 19-46.
13. Foster NE, Bishop A, Thomas E, Main C, Horne R, Weinman J, et al. Illness perceptions of low back pain patients in primary care: what are they, do they change and are they associated with outcome? Pain 2008; 136: 177-87.
14. Bijsterbosch J, Scharloo M, Visser AW, Watt I, Meulenbelt I, Huizinga TW, et al. Illness perceptions in patients with osteoarthritis: change over time and association with disability. Arthritis Rheum 2009; 61: 1054-61.
15. Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J,. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 2002; 64: 580-6. (Pubitemid 34791160)
16. Broadbent E, Ellis CJ, Thomas J, Gamble G, Petrie KJ,. Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial. J Psychosom Res 2009; 67: 17-23.
17. Dalbeth N, Kumar S, Stamp L, Gow P,. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006; 33: 1646-50. (Pubitemid 44168841)
18. Suppiah R, Dissanayake A, Dalbeth N,. High prevalence of gout in patients with type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors. N Z Med J 2008; 121: 43-50.
19. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF,. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
20. Broadbent E, Petrie KJ, Main J, Weinman J,. The brief illness perception questionnaire. J Psychosom Res 2006; 60: 631-7. (Pubitemid 43786439)
21. Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, Teran-Estrada L, Bernard-Medina AG, Espinoza J, et al. Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 2008; 59: 665-9. (Pubitemid 351679541)
22. Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N,. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 2008; 26: 620-6.
23. Ten Klooster PM, Oude Voshaar MA, Taal E, van de Laar MA,. Comparison of measures of functional disability in patients with gout. Rheumatology (Oxford) 2011; 50: 709-13.
24. Horne R, Weinman J,. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-67. (Pubitemid 30029305)
25. Chen SL, Tsai JC, Lee WL,. The impact of illness perception on adherence to therapeutic regimens of patients with hypertension in Taiwan. J Clin Nurs 2009; 18: 2234-44.
26. Gauchet A, Tarquinio C, Fischer G,. Psychosocial predictors of medication adherence among persons living with HIV. Int J Behav Med 2007; 14: 141-50. (Pubitemid 47548111)
27. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N,. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2010; 17: 1-6.
28. Klemp P, Stansfield SA, Castle B, Robertson MC,. Gout is on the increase in New Zealand. Ann Rheum Dis 1997; 56: 22-6. (Pubitemid 27060568)
29. Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM,. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007; 46: 1804-7. (Pubitemid 350168295)
30. Scharloo M, Kaptein AA, Weinman JA, Hazes JM, Breedveld FC, Rooijmans HG,. Predicting functional status in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1686-93. (Pubitemid 29367306)
31. Petrie KJ, Perry K, Broadbent E, Weinman J,. A text message program designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol 2011. In press.